We are live on
!
Find out more
NMC
NEA Management Company Portfolio holdings
AUM
$1.76B
1-Year Est. Return
223.33%
This Fund
S&P 500
This Quarter
Est. Return
+14.5%
1 Year Est. Return
+223.33%
3 Year Est. Return
+769.45%
5 Year Est. Return
+668.45%
10 Year Est. Return
+14,843.34%
AUM
$1.76B
AUM Growth
-$202M
(-10%)
Cap. Flow
-$266M
Cap. Flow
% of AUM
-15.09%
Top 10 Holdings %
Top 10 Hldgs %
87.55%
Holding
28
New
1
Increased
2
Reduced
2
Closed
2
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
SGP
SpyGlass Pharma
SGP
|
+$199M |
| 2 |
ZBIO
Zenas BioPharma
ZBIO
|
+$11.2M |
| 3 |
Korro Bio
KRRO
|
+$2.28M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Rhythm Pharmaceuticals
RYTM
|
+$311M |
| 2 |
Celcuity
CELC
|
+$136M |
| 3 |
Gossamer Bio
GOSS
|
+$26.9M |
| 4 |
SYBX
Synlogic
SYBX
|
+$3.27M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 95.74% |
| 2 | Consumer Staples | 4.26% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
IMA
26
ImageneBio Inc
IMA
$60.7M
| $250K | 0.01% |
50,005
| – | – |
|
|
27
Rhythm Pharmaceuticals
RYTM
$7.31B
| – | – |
-2,909,956
| Closed | -$311M |
|
|
SYBX
28
DELISTED
Synlogic
SYBX
| – | – |
-2,922,772
| Closed | -$3.27M |
|
Similar funds
NM
EK
SLF
PCA
CCIA
SRIM
SW
CGH
NEA Management Company's Q1 2026 Portfolio in Review
As of Q1 2026, NEA Management Company held 28 positions worth $1.76B, down 10% from $1.96B the previous quarter. Its ten largest holdings account for 88% of the portfolio.
NEA Management Company withdrew a net $266M in Q1 2026, closing 2 positions and reducing 2 holdings. Its most notable exit was Rhythm Pharmaceuticals, an estimated $311M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 96% of assets, up from 95% a quarter earlier, followed by Consumer Staples.
Against the trend, NEA Management Company opened a new position in SpyGlass Pharma worth $192M.
- NEA Management Company's largest Q1 2026 buy was SpyGlass Pharma: 7,392,301 shares worth $192M.
- NEA Management Company added most to Zenas BioPharma in Q1 2026, an estimated $11.2M increase.
- NEA Management Company's biggest Q1 2026 reduction was Celcuity, cutting an estimated $136M.
- NEA Management Company fully exited Rhythm Pharmaceuticals in Q1 2026, selling an estimated $311M.
- NEA Management Company's ten largest holdings make up 88% of its $1.76B portfolio in Q1 2026.
- NEA Management Company opened 1 new position and closed 2 in Q1 2026.
- NEA Management Company's portfolio value fell 10% quarter-over-quarter to $1.76B.
Based on NEA Management Company's 13F filing for Q1 2026, filed 15 May 2026.